AFDOL ORAL 120 ML

AFDOL ORAL 120 ML contains Memantine as its active ingredient. Memantine is a medication used primarily for the treatment of Alzheimer’s disease and other neurodegenerative disorders.

Mechanism of Action:

Memantine works by blocking the activity of glutamate, a neurotransmitter involved in learning and memory processes. By modulating the activity of glutamate receptors in the brain, Memantine helps to regulate the excessive stimulation that can lead to neuronal damage and cognitive decline in conditions such as Alzheimer’s disease.

Uses:

AFDOL ORAL 120 ML is prescribed for the following conditions:

• Alzheimer’s disease: to improve cognitive function, behavior, and activities of daily living in patients with moderate to severe Alzheimer’s disease
• Other neurodegenerative disorders: Memantine may also be used off-label for the treatment of other neurodegenerative disorders such as vascular dementia or Parkinson’s disease dementia, as determined by a healthcare professional.

Administration:

AFDOL ORAL 120 ML is taken orally, usually once daily, with or without food. The dosage and duration of treatment depend on the severity of the condition being treated and the patient’s response to therapy. It is important to measure the prescribed dose using the provided measuring device or syringe to ensure accurate dosing.

Side Effects:

Common side effects of AFDOL ORAL 120 ML may include:

• Dizziness
• Headache
• Fatigue
• Confusion
• Constipation
• Cough
• Hallucinations
• Increased blood pressure

Precautions:

Before using AFDOL ORAL 120 ML, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. Memantine should be used with caution in patients with a history of seizures, renal impairment, or urinary tract infections. Regular monitoring of renal function is recommended during treatment.

Contraindications:

AFDOL ORAL 120 ML is contraindicated in patients with a known hypersensitivity to Memantine or any other components of the solution. It should not be used in patients with severe renal impairment (creatinine clearance < 9 mL/min) or those undergoing hemodialysis.

Conclusion:

AFDOL ORAL 120 ML, containing Memantine, is an effective medication for the treatment of Alzheimer’s disease and other neurodegenerative disorders. Patients should use this medication as directed by their healthcare provider and be aware of potential side effects. It is essential to adhere to the prescribed dosage regimen and seek medical advice if experiencing any concerning symptoms.